Mon, Oct 20, 2014, 5:55 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • jrus2010 jrus2010 Jan 30, 2012 11:00 PM Flag

    Ex-US sales of teleprevir

    Just to review ex-US status of teleprevir:

    UK – approved in Sept 2011, marketed by Janssen (J&J sub)
    Germany – approved in Sept 2011, marketed by Janssen (J&J sub)
    France – approved in Sept 2011, marketed by Janssen (J&J sub)
    Sweden – approved in Sept 2011, marketed by Janssen (J&J sub)
    Canada - approved in Q311, marketed by Vertex
    Japan – approved in Q311, marketed by Mitsubishi Tanabe Pharma

    Ex-US sales were not a significant part of Q3 sales, but will be major for Q4. These sales are not easily tracked or captured by IMS and other prescription databases. The J&J Janssen sales force is very capable in Europe so we will see a nice surprise come Thursday.

 
VRTX
104.77+2.42(+2.36%)Oct 20 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.